AET has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AET has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Aetna's change in receivables for the quarter that ended in Sep. 2018 was $-529 Mil. It means Aetna's Accounts Receivable increased by $529 Mil from Jun. 2018 to Sep. 2018 .
Aetna's change in receivables for the fiscal year that ended in Dec. 2017 was $-809 Mil. It means Aetna's Accounts Receivable increased by $809 Mil from Dec. 2016 to Dec. 2017 .
Aetna's Accounts Receivable for the quarter that ended in Sep. 2018 was $6,724 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Aetna's Days Sales Outstanding for the three months ended in Sep. 2018 was 39.63.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aetna's liquidation value for the three months ended in Sep. 2018 was $-24,082 Mil.
The historical data trend for Aetna's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aetna Annual Data | |||||||||||||||||||||
Trend | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | -261.70 | -784.00 | -616.00 | -153.00 | -809.00 |
Aetna Quarterly Data | ||||||||||||||||||||
Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | |
Change In Receivables | Get a 7-Day Free Trial | 1,151.00 | -625.00 | -384.00 | 427.00 | -529.00 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,111 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aetna (NYSE:AET) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Aetna's Days Sales Outstanding for the quarter that ended in Sep. 2018 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 6724 | / | 15484 | * | 91 |
= | 39.63 |
2. In Ben Graham's calculation of liquidation value, Aetna's accounts receivable are only considered to be worth 75% of book value:
Aetna's liquidation value for the quarter that ended in Sep. 2018 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 9415 | - | 38540 | + | 0.75 * 6724 | + | 0.5 * 0 |
= | -24,082 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Aetna's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Fernando Aguirre | director | CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202 |
Harold L Paz | officer: EVP & Chief Medical Officer | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Molly Joel Coye | director | AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Jeffrey E Garten | director | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Frank M Clark | director | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Shawn M Guertin | officer: Exec. Vice President, CFO | TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568 |
Mark T Bertolini | director, officer: Chairman and CEO | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Karen S Lynch | officer: President | 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156 |
Roger N Farah | director | POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022 |
Ellen M Hancock | director | 126 LIMESTONE ROAD, RIDGEFIELD CT 06877 |
Edward J Ludwig | director | C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417 |
Margaret M Mccarthy | officer: EVP, Operations & Technology | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Olympia J. Snowe | director | 100 E. PRATT STREET, BALTIMORE MD 21202 |
Heather Brianne Dixon | officer: VP, Controller & CAO | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
Sabatino Thomas J Jr | officer: EVP & General Counsel | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
From GuruFocus
By Sydnee Gatewood Sydnee Gatewood • 08-25-2017
By Jimmy Xiao gurujx • 05-11-2015
By PRNewswire PRNewswire • 12-30-2019
By Sally Jones Sally Jones • 11-25-2013
By Mark Yu Mark Yu • 10-31-2016
By Victor Selva Victor Selva • 03-24-2014
By Mark Yu Mark Yu • 02-16-2016
By Tiziano Frateschi Tiziano Frateschi • 03-12-2018
By Tiziano Frateschi Tiziano Frateschi • 01-14-2015
By Victor Selva Victor Selva • 12-16-2013
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.